The ample evidence above indicates that lung infection and inflammation may lead to the onset of AE and upregulation of GDF-15 in IPF subjects, which can further cause metabolic disorders of lipid and protein and coagulation dysfunction and then aggravate the conditions of these patients. The gene discussed is GDF15; the disease is Other metabolic disease.